Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Effects of 16S rRNA gene mutations on tetracycline resistance in Helicobacter pylori.

Gerrits MM, Berning M, Van Vliet AH, Kuipers EJ, Kusters JG.

Antimicrob Agents Chemother. 2003 Sep;47(9):2984-6.

2.

16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori.

Gerrits MM, de Zoete MR, Arents NL, Kuipers EJ, Kusters JG.

Antimicrob Agents Chemother. 2002 Sep;46(9):2996-3000.

3.

Detection of high-level tetracycline resistance in clinical isolates of Helicobacter pylori using PCR-RFLP.

Ribeiro ML, Gerrits MM, Benvengo YH, Berning M, Godoy AP, Kuipers EJ, Mendonça S, van Vliet AH, Pedrazzoli J Jr, Kusters JG.

FEMS Immunol Med Microbiol. 2004 Jan 15;40(1):57-61.

4.

Real-time PCR detection of a 16S rRNA single mutation of Helicobacter pylori isolates associated with reduced susceptibility and resistance to tetracycline in the gastroesophageal mucosa of individual hosts.

Contreras M, Benejat L, Mujica H, Peña J, García-Amado MA, Michelangeli F, Lehours P.

J Med Microbiol. 2019 Sep;68(9):1287-1291. doi: 10.1099/jmm.0.001051.

PMID:
31364966
5.
6.

Real-time PCR detection of 16S rRNA novel mutations associated with Helicobacter pylori tetracycline resistance in Iran.

Dadashzadeh K, Milani M, Rahmati M, Akbarzadeh A.

Asian Pac J Cancer Prev. 2014;15(20):8883-6.

7.

Real-time PCR screening for 16S rRNA mutations associated with resistance to tetracycline in Helicobacter pylori.

Glocker E, Berning M, Gerrits MM, Kusters JG, Kist M.

Antimicrob Agents Chemother. 2005 Aug;49(8):3166-70.

8.

Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16S ribosomal DNA and other genetic loci.

Dailidiene D, Bertoli MT, Miciuleviciene J, Mukhopadhyay AK, Dailide G, Pascasio MA, Kupcinskas L, Berg DE.

Antimicrob Agents Chemother. 2002 Dec;46(12):3940-6.

9.

Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes.

Wu JY, Kim JJ, Reddy R, Wang WM, Graham DY, Kwon DH.

Antimicrob Agents Chemother. 2005 Feb;49(2):578-83.

10.
11.
12.
14.

Molecular analysis of low-level tetracycline resistance in clinical isolates of Helicobacter pylori among dyspeptic patients in South West Nigeria.

Seriki AT, Smith SI, Adeleye AI, Fowora MA.

J Glob Antimicrob Resist. 2018 Jun;13:143-145. doi: 10.1016/j.jgar.2018.01.003. Epub 2018 Jan 31.

PMID:
29355664
15.

Isolation of tetracycline-resistant clinical Helicobacter pylori without mutations in 16S rRNA gene in Bangladesh.

Khan R, Nahar S, Mukhopadhyay AK, Berg DE, Ahmad MM, Okamoto K, Nair GB, Rahman M.

Microbiol Immunol. 2008 Oct;52(10):508-11. doi: 10.1111/j.1348-0421.2008.00062.x.

16.

Tetracycline resistance in Chilean clinical isolates of Helicobacter pylori.

Toledo H, López-Solís R.

J Antimicrob Chemother. 2010 Mar;65(3):470-3. doi: 10.1093/jac/dkp457. Epub 2009 Dec 24.

PMID:
20035020
17.
18.

16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium.

Ross JI, Eady EA, Cove JH, Cunliffe WJ.

Antimicrob Agents Chemother. 1998 Jul;42(7):1702-5.

19.

Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany.

Wueppenhorst N, Stueger HP, Kist M, Glocker E.

J Antimicrob Chemother. 2009 Apr;63(4):648-53. doi: 10.1093/jac/dkp003. Epub 2009 Feb 3.

PMID:
19190100
20.

Proton motive force-dependent efflux of tetracycline in clinical isolates of Helicobacter pylori.

Anoushiravani M, Falsafi T, Niknam V.

J Med Microbiol. 2009 Oct;58(Pt 10):1309-13. doi: 10.1099/jmm.0.010876-0. Epub 2009 Jul 2.

PMID:
19574414

Supplemental Content

Support Center